Megaprosthesis for Metastatic Bone Disease—A Comparative Analysis
Background: Megaprosthetic reconstruction is sometimes indicated in advanced metastatic bone disease (MBD) of the appendicular skeleton with large degrees of bone loss or need for oncological segmental resection. Outcome after megaprosthetic reconstruction was studied in the setting of primary bone...
Main Authors: | Joachim Thorkildsen, Thale Asp Strøm, Nils Jørgen Strøm, Simen Sellevold, Ole-Jacob Norum |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2022-05-01
|
Series: | Current Oncology |
Subjects: | |
Online Access: | https://www.mdpi.com/1718-7729/29/5/279 |
Similar Items
-
A Combined Use of Custom-Made Partial Pelvic Replacement and Proximal Femur Megaprosthesis in the Treatment of Severe Bone Loss after Multiple Total Hip Arthroplasty Revisions
by: Michele Fiore, et al.
Published: (2023-10-01) -
Megaprosthesis in Non-Oncologic Settings—A Systematic Review of the Literature
by: Andrea Sambri, et al.
Published: (2023-06-01) -
Does the Duration of Primary and First Revision Surgery Influence the Probability of First and Subsequent Implant Failures after Extremity Sarcoma Resection and Megaprosthetic Reconstruction?
by: Christoph Theil, et al.
Published: (2021-05-01) -
Surgical Treatment of Bone Sarcoma
by: Felix Bläsius, et al.
Published: (2022-05-01) -
Distal Humeral Replacement in Patients with Primary Bone Sarcoma: The Functional Outcome and Return to Sports
by: Kristian Nikolaus Schneider, et al.
Published: (2023-07-01)